Bio-inspired biopolymeric coacervation for entrapment and targeted release of anthocyanin
Sign Up to like & getrecommendations! Published in 2020 at "Cellulose"
DOI: 10.1007/s10570-020-03523-w
Abstract: In order to provide stability of anthocyanin, a powerful antioxidant, encapsulant was made by utilizing two biopolymers that can be used further for the targeted release due to its intrinsic structure. Present study was carried… read more here.
Keywords: targeted release; bio inspired; biopolymeric coacervation; anthocyanin ... See more keywords
Childhood IgA Nephropathy Successfully Treated with Targeted‐Release Budesonide: A Case Report
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Paediatrics and Child Health"
DOI: 10.1111/jpc.14259
Abstract: Idiopathic immunoglobulin-A (IgA) nephropathy is a primary glomerulonephritis with varying clinical presentations. Treatment regimens are often poorly tolerated and yield variable results. The NEFIGAN Trial (targeted-release budesonide vs. placebo in patients with IgA nephropathy) demonstrated… read more here.
Keywords: trial; iga nephropathy; release budesonide; targeted release ... See more keywords
Current knowledge of targeted-release budesonide in immunoglobulin A nephropathy: A comprehensive review
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.926517
Abstract: Immunoglobulin A (IgA) nephropathy is a common autoimmune kidney disease. Accumulating studies showed that IgA nephropathy may be partially correlated with mucosal immune system dysfunction. Systemic corticosteroid treatment exerts an essential protective effect against renal… read more here.
Keywords: review; iga nephropathy; targeted release; trf budesonide ... See more keywords